<main class="html-publication" lang="en" role="main">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--single-identity brand__border-color" href="/government/organisations/uk-health-security-agency">
      <span class="gem-c-organisation-logo__name">UK Health<br>Security<br>Agency</span>
</a>
</div>
        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  

<div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>


  <h1 class="gem-c-title__text govuk-heading-xl">
    COVID-19 vaccine product information
  </h1>
</div>
  <p class="publication-header__last-changed">Updated 23 February 2022</p>

  </header>



<div class="govuk-grid-row sidebar-with-body" data-module="sticky-element-container">

  <div class="print-wrapper">
    <div class="print-meta-data">
      <p>
  <img class="print-meta-data-licence" src="/assets/government-frontend/open-government-licence-min-e98134ae65ff5fe99a524d8c383350b3998f91c298dc24b36126e65f1656c578.png">
</p>
<p>
  © Crown copyright 2022
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/publications/covid-19-vaccination-vaccine-product-information-poster/which-covid-19-vaccine
</p>


    </div>
  </div>

  <div class="main-content-container offset-empty-contents-list">
    <div class="gem-c-govspeak-html-publication">
  
<div class="gem-c-govspeak govuk-govspeak " data-module="govspeak">
    
    
      <div class="govspeak">
<table>
  <thead>
    <tr>
      <td></td>
      <th scope="col">Comirnaty 30 micrograms/dose concentrate (Pfizer BioNTech)</th>
      <th scope="col">Comirnaty 10 micrograms/dose concentrate (Pfizer BioNTech)</th>
      <th scope="col">AstraZeneca</th>
      <th scope="col">Spikevax (Moderna)</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Dose</td>
      <td>0.3 ml (30 micrograms) by intramuscular injection</td>
      <td>0.2 ml (10 micrograms) by intramuscular injection</td>
      <td>0.5 ml by intramuscular injection</td>
      <td>0.5 ml (100 micrograms) primary dose or  0.25ml (50 micrograms) booster dose by intramuscular injection</td>
    </tr>
    <tr>
      <td>Age</td>
      <td>12 years of age and older</td>
      <td>Children 5 to 11 years of age<sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td>See current JCVI guidance available in the <a class="govuk-link" href="https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a">Green book</a>
</td>
      <td>See current JCVI guidance available in the <a class="govuk-link" href="https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a">Green book</a>
</td>
    </tr>
    <tr>
      <td>Number of doses per vial</td>
      <td>6</td>
      <td>10</td>
      <td>8</td>
      <td>10 doses of 0.5ml or a maximum of 20 doses of 0.25ml</td>
    </tr>
    <tr>
      <td>Dilution required?</td>
      <td>Yes with 1.8 ml sodium chloride 0.9% solution for injection</td>
      <td>Yes with 1.3 ml sodium  chloride 0.9% solution for injection</td>
      <td>No</td>
      <td>No</td>
    </tr>
    <tr>
      <td>Refrigerated storage</td>
      <td>Thawed, unopened and undiluted:  up to 1 month at +2°C to +8°C</td>
      <td>Thawed, unopened and undiluted: up to 10 weeks at +2°C to +8°C</td>
      <td>Unopened: up to 6 months at +2°C to +8°C</td>
      <td>Thawed, unopened and undiluted: up to 30 days at +2°C to +8°C</td>
    </tr>
    <tr>
      <td>Room temperature stability</td>
      <td>Prior to use, the unopened vials can be stored up to 2 hours at temperatures up to 30°C</td>
      <td>Prior to use, the unopened vials can be stored up to 12 hours at temperatures up to 30°C</td>
      <td>Not applicable</td>
      <td>Unopened vaccine may be stored at 8°C to 25°C up to 24 hours after removal from refrigerated conditions</td>
    </tr>
    <tr>
      <td>Stability after first puncture</td>
      <td>Once diluted use within 6 hours. May be stored between +2°C and +30°C during this 6 hour period</td>
      <td>Once diluted use within 12 hours. May be stored between +2°C and +30°C during this 12 hour period</td>
      <td>Use within 6 hours of first puncture. May be stored between +2°C and +25°C during this 6 hour period</td>
      <td>Use within 6 hours of first puncture. May be stored between +2°C and +25°C during this 6 hour period</td>
    </tr>
    <tr>
      <td>Appearance</td>
      <td>Prior to dilution, the thawed dispersion may contain white to off-white opaque amorphous particles. The diluted vaccine should present as an off-white dispersion with no particulates visible</td>
      <td>Prior to dilution, the thawed dispersion may contain white to off-white opaque amorphous particles. The diluted vaccine should present as a white to off-white dispersion with no particulates visible</td>
      <td>Colourless to slightly brown, clear to slightly opaque</td>
      <td>White to off-white dispersion</td>
    </tr>
    <tr>
      <td>Notable excipients</td>
      <td>Contains Polyethylene Glycol (PEG)</td>
      <td>Contains Polyethylene Glycol (PEG)</td>
      <td>Contains Polysorbate 80</td>
      <td>Contains Polyethylene Glycol (PEG)</td>
    </tr>
  </tbody>
</table>

<p>Further information on the <a class="govuk-link" href="https://www.gov.uk/government/collections/covid-19-vaccination-programme">COVID-19 vaccination programme</a> is available in the <a class="govuk-link" href="https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a">COVID-19 Green Book, chapter 14a</a>.</p>

<div class="footnotes" role="doc-endnotes">
  <ol>
    <li role="doc-endnote">
      <p>Children aged 5 to 11 years who commence immunisation with the 10 microgram dose and then turn 12 years of age should complete vaccination with the 10 microgram dose.&nbsp;<a aria-label="go to where this is referenced" class="govuk-link" href="#fnref:1" role="doc-backlink">↩</a></p>
    </li>
  </ol>
</div>
</div>


</div>
</div>
  </div>

  <div class="sticky-element" data-sticky-element="">
    <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" focusable="false" height="17" viewBox="0 0 13 17" width="13" xmlns="http://www.w3.org/2000/svg">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Contents
</a>

    <div class="sticky-element__print-link">
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>
  </div>
</div>

    </main>